Aptus Pharma Limited has submitted a regulatory disclosure to BSE Ltd regarding scheduled investor interactions.
Nature of Disclosure: The company is intimating the exchange about upcoming investor meetings as required under SEBI Listing Regulations.
Regulatory Reference: This disclosure is made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Meeting Details:
- Date: Friday, September 18, 2026
- Time: 4:00 PM to 6:00 PM
- Event Type: Investor Meetings
- Interaction Type: Group Meeting with Investors/Analysts
- Venue: Mumbai
Discussion Content: The management confirmed that all discussions during these meetings will be based exclusively on publicly available information about the company.
Contingency Note: The disclosure includes a note that changes to the schedule may occur due to exigencies on the part of either participants or the company.
- DIN: 03151221
- Signature Date: September 12, 2026 at 12:57:00 IST
Financial Impact: No financial impact or material business updates are disclosed in this filing. The document serves solely as a notice of scheduled investor interactions.